Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (<i>MTAP</i>) loss

Maroun Bou Zerdan, Prashanth Ashok Kumar, Elio Haroun, Nimisha Srivastava, Jeffrey Ross, Abirami Sivapiragasam

Open source

DOI
10.18632/oncotarget.28481
Published
2023-01-12
Container
Oncotarget
Publisher
Impact Journals, LLC
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.18632/oncotarget.28481,
  title = {Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (<i>MTAP</i>) loss},
  author = {Maroun Bou Zerdan and Prashanth Ashok Kumar and Elio Haroun and Nimisha Srivastava and Jeffrey Ross and Abirami Sivapiragasam},
  year = {2023},
  journal = {Oncotarget},
  doi = {10.18632/oncotarget.28481},
  url = {https://doi.org/10.18632/oncotarget.28481}
}

RIS

TY  - JOUR
TI  - Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (<i>MTAP</i>) loss
AU  - Maroun Bou Zerdan
AU  - Prashanth Ashok Kumar
AU  - Elio Haroun
AU  - Nimisha Srivastava
AU  - Jeffrey Ross
AU  - Abirami Sivapiragasam
PY  - 2023
JO  - Oncotarget
DO  - 10.18632/oncotarget.28481
UR  - https://doi.org/10.18632/oncotarget.28481
ER  - 

APA

Zerdan, M. B., Kumar, P. A., Haroun, E., Srivastava, N., Ross, J., & Sivapiragasam, A. (2023). Addendum: Genomic landscape of metastatic breast cancer (MBC) patients with methylthioadenosine phosphorylase (<i>MTAP</i>) loss. Oncotarget. https://doi.org/10.18632/oncotarget.28481

Source records